Investing.com - Financial Markets Worldwide
Open in App

Easy Bio Inc (353810)

KOSDAQ
Currency in KRW
6,060
-100(-1.62%)
Closed·

353810 Income Statement

Period Ending:
2021
31/12
2022
31/12
2023
31/12
2024
31/12
2025
31/12
Total Revenues
129,457.81155,557.1165,385.09384,330.91476,938.92
Total Revenues Growth
-+20.16%+6.32%+132.39%+24.1%
Cost Of Revenues
89,387.63108,612.03113,681.78286,242.94356,445.52
Gross Profit
40,070.1746,945.0751,703.3198,087.97120,493.4
Gross Profit Growth
-+17.16%+10.14%+89.71%+22.84%
Gross Profit Margin %
30.95%30.18%31.26%25.52%25.26%
Other Operating Expenses, Total
23,290.7130,789.7831,072.0965,696.7475,503.6
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
-+32.2%+0.92%+111.43%+14.93%
1,743.662,426.382,486.983,034.023,118.38
20,768.4927,230.6927,184.9957,196.2466,269.88
167.89217.04268.542,140.042,282.67
Operating Income
16,779.4716,155.2920,631.2232,391.2344,989.8
Operating Income Growth
--3.72%+27.71%+57%+38.89%
EBIT Margin %
12.96%10.39%12.47%8.43%9.43%
Net Interest Expenses
-757.1-1,185.76-1,886.17-5,725.19-5,060.24
Net Interest Expenses Growth
--56.62%-59.07%-203.54%+11.61%
Interest Expense, Total
-1,104.96-1,720.3-3,219.27-9,024.53-7,535.15
Interest And Investment Income
347.87534.541,333.13,299.342,474.92
Other Non Operating Expenses, Total
-1,981.26-3,577.25-896.61,029.63-2,084.67
EBT, Excl. Unusual Items
14,041.1111,392.2817,848.4527,695.6837,844.89
Gain (Loss) On Sale Of Assets
0.9-0.33-7.04-114.654.76
Other Unusual Items, Total
----2,240.67-
EBT, Incl. Unusual Items
14,054.0611,984.0920,065.626,375.5838,656.88
EBT, Incl. Unusual Items Growth
--14.73%+67.44%+31.45%+46.56%
EBT, Incl. Unusual Items Margin
10.86%7.7%12.13%6.86%8.11%
Income Tax Expense
3,211.992,636.743,964.566,472.029,385.34
Net Income to Company
10,842.079,347.3516,101.0419,903.5729,271.55
Minority Interest
30.73-216.61-557.26-299.18-1,493.88
Net Income
10,872.89,130.7415,543.7819,604.3927,777.67
Net Income Growth
--16.02%+70.24%+26.12%+41.69%
Net Income Margin %
8.4%5.87%9.4%5.1%5.82%
Preferred Dividend and Other Adjustments
-----
Net Income to Common Excl. Extra Items
10,872.89,130.7415,543.7819,604.3927,777.67
Basic EPS - Continuing Operations
318.5267.47455.33579.08839.66
Basic EPS - Continuing Operations Growth
--16.02%+70.24%+27.18%+45%
Diluted EPS - Continuing Operations
318.5267455579839.66
Diluted EPS - Continuing Operations Growth
--16.17%+70.41%+27.25%+45.02%
Basic Weighted Average Shares Outstanding
34.1434.1434.1433.8533.08
Diluted Weighted Average Shares Outstanding
34.1434.1434.1433.8533.08
Dividend Per Share
7575100200250
Dividend Per Share Growth
-0%+33.33%+100%+25%
EBITDA
19,580.219,918.2924,323.1439,896.253,318.84
EBITDA Growth
-+1.73%+22.11%+64.03%+33.64%
EBITDA Margin %
15.12%12.8%14.71%10.38%11.18%
EBIT
16,779.4716,155.2920,631.2232,391.2344,989.8
* In Millions of KRW (except for per share items)

FAQ

What was Easy Bio’s revenue at year end?

At the end of the last reported fiscal year, Easy Bio (353810) recorded total revenue of 476,939 million KRW.

How much revenue did Easy Bio report in the most recent quarter?

In its most recent quarterly earnings report, Easy Bio posted revenue of 130,692 million KRW.

What was Easy Bio’s net income for the year?

For the full year, Easy Bio reported net income of 27,778 million KRW.

How much net income did Easy Bio post in the last quarter?

In the most recent quarter, Easy Bio (353810) posted net income of 11,188 million KRW.

What was Easy Bio’s gross profit for the year?

Gross profit for the year was reported at 120,493 million KRW.

How much gross profit did Easy Bio generate last quarter?

Easy Bio recorded gross profit of 34,745 million KRW in its latest quarterly report.

What was Easy Bio’s annual operating income?

For the full year, Easy Bio (353810) reported operating income of 44,990 million KRW.

What was Easy Bio’s operating income last quarter?

Quarterly operating income was 13,217 million KRW.

What was Easy Bio’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 15,342 million KRW.

What was the quarter-over-quarter change in EBITDA for Easy Bio?

EBITDA changed by -2% million KRW compared to the last quarter.

What is Easy Bio’s most recent gross profit margin?

The latest reported gross profit margin for Easy Bio (353810) is 27% million KRW.

What is Easy Bio’s most recent net income margin?

Net income margin based on recent financials is 9% million KRW.

What is Easy Bio’s most recent EBIT margin?

Easy Bio reported an EBIT margin of 10% million KRW based on current figures.

How did Easy Bio’s revenue change compared to the previous quarter?

Revenue changed by 1% million KRW compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Easy Bio?

In the latest quarter, gross profit changed by -3% million KRW from the previous quarter.
Install Our App
Follow us
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.